TAPERDEX

Live / Registered — Registered (as of 29 Oct 2019)

What this means for you

Registered since 29 Oct 2019. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
88139955
Registration number
5898677
Mark type
Stylized text
Filed
02 Oct 2018
Published for opposition
05 Mar 2019
Registered
29 Oct 2019
Attorney of record
Mindi M. Richter

Goods and services

  • Class 005 — Pharmaceuticals: A prescription pharmaceutical with a corticosteroid as its primary ingredient for the treatment of allergic states, dermatologic diseases, endocrine disorders, gastrointestinal diseases, hematologic disorders, neoplastic diseases, nervous system disorders, renal diseases, respiratory diseases, and rheumatic disorders; A pharmaceutical product using dexamethasone in a fixed prescription packaging for the treatment of allergic states, dermatologic diseases, endocrine disorders, gastrointestinal diseases, hematologic disorders, neoplastic diseases, nervous system disorders, renal diseases, respiratory diseases, and rheumatic disorders

Owner

Prosecution history

  • 29 Oct 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
  • 27 Oct 2020 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
  • 27 Oct 2020 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
  • 27 Oct 2020 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
  • 27 Oct 2020 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
  • 27 Oct 2020 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
  • 29 Oct 2019 — REGISTERED-PRINCIPAL REGISTER
  • 26 Sept 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
  • 25 Sept 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
  • 21 Sept 2019 — STATEMENT OF USE PROCESSING COMPLETE
  • 29 Aug 2019 — USE AMENDMENT FILED
  • 21 Sept 2019 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
  • 29 Aug 2019 — TEAS STATEMENT OF USE RECEIVED
  • 27 Aug 2019 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
  • 14 Jul 2019 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED

View this trademark record on Marksy